Targeting the cholinergic anti-inflammatory pathway for type 2 diabetes prevention: A retrospective cohort study. - Magagnoli J; Cummings TH; Hardin JW; Ambati J; Sutton SS (Diabetes, obesity & metabolism, 2025)